Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review.

NPJ Precis Oncol · 2021 · PMC7820397 · PMID 33479481

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0660

boldest claim

The sentences

borderline significantp = 0.054so close (0.05 < p ≤ 0.1)

In the same vein, our study revealed lower ORs in the high metastatic burden subgroup than in the low metastatic burden subgroup with a borderline significant difference ( p = 0.054).

also in 11,409 other papers

a nonsignificant trendp = 0.054so close (0.05 < p ≤ 0.1)

The pooled ORs for OS according to high versus low metastatic burden studies were 2.23 (95% CI: 1.56–3.20, p < 0.001) and 4.32 (95% CI: 2.45–7.59, p < 0.001), respectively, although the difference between these subgroups had a nonsignificant trend ( p = 0.054).

also in 5,406 other papers

borderline significancep = 0.066so close (0.05 < p ≤ 0.1)

Of note, the benefit of LCTs in terms of OS and PFS in patients with colorectal cancer showed borderline significance in the pooled analyses ( p = 0.066 and 0.055, respectively).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.